Wang, E. S., Cortes, J. E., Wei, A. H., Botton, S. D., Curti, A., Montesinos, P., Yee, K. W., Jurcic, J. G., Donnellan, W. B., Yang, J., Jonas, B. A., Sheppard, A., Tian, H., Watts, J. M. (2025). A phase 2 study of olutasidenib in relapsed/refractory acute myeloid leukemia: Outcomes by number of prior treatment regimens.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6545